F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
Based on clinical records reviews and staff interviews, it was determined that the facility failed to follow
physician's orders related to bowel medications for one of six residents reviewed (Resident 2).
Residents Affected - Few
Findings include:
An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 2, dated December 23, 2025, revealed that the resident was understood, could
understand others, was cognitively intact, and was occasionally incontinent of bowel.
Physician's orders for Resident 2, dated December 19, 2024, included orders for the resident to receive 30
milliliters (mL) of Milk of Magnesia (an oral laxative) as needed for constipation if no bowel movement by
the third day. If the Milk of Magnesia (MOM) was not effective then one Bisacodyl suppository (a laxative
inserted rectally) was to be administered as needed for constipation. If there were no results from the MOM
or suppository, then one Fleets enema (a liquid inserted rectally to stimulate a bowel movement) was to be
administered as needed for constipation.
Resident 2's bowel records revealed that she did not have a bowel movement from December 30, 2024,
through January 5, 2025 (seven days). The resident's Medication Administration Record (MAR) for January
2025 revealed that staff administered 30 mL of MOM on January 5, 2025, at 1:03 p.m. and a Bisacodyl
suppository at 10:08 p.m.
Resident 2's bowel records revealed that she did not have a bowel movement from January 17 through 27,
2025 (11 days). The resident's MAR for January 2025 revealed that staff administered 30 mL of MOM on
January 26, 2025, at 8:26 a.m. and a Bisacodyl suppository at 7:23 p.m.
Interview with the Nursing Home Administrator on March 4, 2025, at 3:44 p.m. confirmed that Resident 2's
physician orders for bowel medications were not followed.
28 Pa. Code 211.12(d)(3)(5) Nursing Services.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
395860
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395860
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Loyalhanna Care Center
535 McFarland Road
Latrobe, PA 15650
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0692
Provide enough food/fluids to maintain a resident's health.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of facility policies and residents' clinical records, as well as staff interviews, it was
determined that the facility failed to ensure that the residents maintained acceptable parameters for
nutritional status by failing to ensure timely notification of the dietician and physician about significant
weight losses for two of six residents reviewed (Residents 1, 2), resulting in a delay in treatment for
Resident 2, and failing to ensure timely notification of the physician about a decline in hydration
consumption for one of six residents reviewed (Resident 2).
Residents Affected - Few
Findings include:
The facility's policy regarding weight assessment and intervention, dated January 13, 2025, indicated that if
any resident had a weight change of five percent or more since the last weight, they would have the weight
re-taken the next day for confirmation. If the weight was verified, nursing would immediately notify the
dietitian/designee. The physician and the multidisciplinary team will identify conditions and medications that
may be causing anorexia (an eating disorder that involves severe calorie restriction and often a low body
weight), weight loss, or increasing the risk of weight loss.
An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 1, dated January 28, 2025, revealed that the resident was understood and could
understand others, weighed 150 pounds, and was on a therapeutic diet (e.g., low salt, diabetic, low
cholesterol). A care plan for the resident, dated January 24, 2025, revealed that the resident has a potential
to have a nutritional problem related to requiring a therapeutic diet. Staff was to monitor the resident's
weights as ordered and notify the physician with any significant changes. Staff was also to
monitor/record/report to the physician any significant weight loss of three pounds in one week, greater than
five percent weight loss in one month, greater than 7.5 percent weight loss in three months, and greater
than 10 percent weight loss in six months.
A dietary note for Resident 1, dated February 11, 2025, revealed that the resident had a significant weight
loss of 6.9 percent (10.5 pounds) in one month. The resident's reweigh on February 4, 2025, was 142
pounds, confirming the weight loss.
There was no documented evidence that the physician was notified about Resident 1's significant weight
loss of 6.9 percent (10.5 pounds) in one month.
Interview with the Director of Nursing on March 4, 2025, at 2:53 p.m. confirmed that there was no
documented evidence that the physician was notified of Resident 1's significant weight loss of 6.9 percent
(10.5 pounds) times one month as per the resident's care plan.
An admission MDS assessment for Resident 2, dated December 23, 2025, revealed that the resident was
understood, could understand others, was cognitively intact, weighed 161 pounds, had no weight loss, had
coughing or choking during meals or when swallowing medications, had difficulty or pain when swallowing,
and was receiving a diuretic (water pill). A care plan, dated December 20, 2024, and January 3, 2025,
indicated that the resident had a potential for fluid volume deficit related to the use of a diuretic. Staff were
to monitor for signs and symptoms of fluid volume deficit. The resident was at risk for nutrition problems and
weights were to be monitored. The physician was to be notified of any significant changes. A physician's
order, dated December 19, 2024, included orders for the resident to receive 20 milligrams(mg) of
Furosemide (diuretic) one time a day.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395860
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395860
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Loyalhanna Care Center
535 McFarland Road
Latrobe, PA 15650
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0692
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
A nutritional assessment, dated December 26, 2024, indicated that the resident's daily fluid intake needs
were 1500-1700 milliliters (mL) and was consuming 240-420 mL of fluids per meal.
Laboratory test results, dated December 31, 2024, revealed that the resident had an elevated blood urea
nitrogen of 30 (7-25 milligrams/deciliter), a low sodium of 131 (136-145 milli-equivalents), and glomerular
filtration rate of 57 (greater than 90).
Daily fluid intake records for January 2025 revealed that the resident's daily fluid intake was 480 mL on
January 27, 600 mL on January 28, 240 mL on January 29, 360 mL on January 30, 480 mL on January 31,
360 mL on February 1, 240 mL on February 2, and 180 mL on February 2, 2025. A care plan, dated
January 29, 2025, indicated that staff were to encourage fluid intake; however there was no documented
evidence that the care plan for dehydration was updated to include any new interventions to increase the
resident's fluid intake and no documented evidence that the physician was notified of the low fluid intake.
Laboratory test results, dated February 3, 2025, revealed that the resident had an elevated blood urea
nitrogen of 48 (7-25 milligrams/deciliter), a low sodium of 123 (136-145 milli-equivalents) and potassium of
2.4 (3.5-5.1), and glomerular filtration rate of 51 (greater than 90).
A weight record, dated January 1, 2025, revealed that Resident 2 weighed 149.6 pounds (11.4 pound loss)
and on January 10, 2025, weighed 147 pounds. There was no documented evidence that the physician
and/or dietitian were notified about the resident's weight loss, and there was no evidence that new
interventions were implemented to improve the resident's meal intake.
A weight record, dated February 2, 2025, revealed Resident 2 weighed 144.6 pounds.
A dietitian note for Resident 2, dated February 4, 2025, revealed that the resident had a 9.6 percent weight
loss over the past two months and poor intake, and 90 milliliters (mL) of med pass 2.0 (supplement) would
be added twice day.
An interview with the Director of Nursing on March 4, 2025, at 2:55 p.m. and 3:44 p.m. confirmed that
Resident 2's decreased fluid intake and weight loss were not reported to the physician or dietitian until
February 4, 2025, when a supplement was ordered.
28 Pa. Code 211.12(d)(3)(5) Nursing Services.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395860
If continuation sheet
Page 3 of 3